Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study

Mariusz Sikora,Norbert Kiss,Albert Stec,Joanna Giebultowicz,Emilia Samborowska,Radoslaw Jazwiec,Michal Dadlez,Malgorzata Olszewska,Lidia Rudnicka
DOI: https://doi.org/10.1007/s13555-021-00547-3
2021-05-13
Dermatology and Therapy
Abstract:Trimethylamine N-oxide (TMAO), a gut microbiota metabolite from dietary phosphatidylcholine, is involved in the pathogenesis of atherosclerosis and cardiovascular diseases. Psoriasis is associated with increased cardiovascular risk that is not captured by traditional biomarkers. The aim of the present study was to assess TMAO concentration in psoriasis and evaluate the relationship between TMAO and cardiovascular risk in psoriatic patients.
dermatology
What problem does this paper attempt to address?